- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/40 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
Patent holdings for IPC class A61K 31/40
Total number of patents in this class: 5279
10-year publication summary
332
|
350
|
349
|
378
|
338
|
383
|
371
|
335
|
318
|
70
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 18943 |
70 |
Novartis AG | 11238 |
63 |
Chiesi Farmaceutici S.p.A. | 940 |
63 |
F. Hoffmann-La Roche AG | 7958 |
52 |
Daiichi Sankyo Company, Limited | 1829 |
46 |
Takeda Pharmaceutical Company Limited | 2961 |
44 |
Amarin Pharmaceuticals Ireland Limited | 267 |
44 |
Bristol-myers Squibb Company | 5080 |
37 |
Allergan, Inc. | 2600 |
34 |
Bodor Laboratories, Inc. | 59 |
33 |
Boehringer Ingelheim International GmbH | 4629 |
32 |
Merck Sharp & Dohme Corp. | 2247 |
30 |
Theravance Biopharma R&D IP, LLC | 550 |
27 |
Merck Sharp & Dohme LLC | 3689 |
27 |
Hoffmann-La Roche Inc. | 3060 |
26 |
Sanofi | 3836 |
26 |
Pfizer Inc. | 3322 |
25 |
Duke University | 2872 |
25 |
Sunovion Pharmaceuticals Inc. | 326 |
25 |
The Scripps Research Institute | 1364 |
24 |
Other owners | 4526 |